1- års patientoverlevelsesraten var 83% i tacrolimusgruppen og 71% i ciclosporingruppen, 2- års patientoverlevelsen var henholdsvis 76% og 66%.
The 1-year patient survival was 83% in the tacrolimus and 71% in the ciclosporin group, the 2-year survival rates were 76% and 66%, respectively.